 The company can be traced back to 1944 as it developed from the non-profit BC Research Council to a private company in 1993, founded by Dr. Hugh Wynne-Edwards, Ph.D, DSc., FRSC, a member of the Order of Canada, who served as the founding Chief Executive Officer and developed the facility into one of Canada's most recognized incubators in the fields of biotechnology, drug discovery and alternative fuel technologies.In 2000, BC Research was purchased by Immune Network Ltd and was sold to Cromedica (now PRA International) in July 2001 for a consideration of $8.3 million according to 2001 audited financials published on SEDAR.Its plant biotechnology team was mostly spun off in Silvagen Inc. which specialized in clonal reforestation and which became a part of CellFor.